pentobarbital will lower the extent or impact of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Carefully. Look at an increase in cannabidiol dosage (determined by clinical reaction and tolerability) when coadministered with a robust CYP3A4 inducer.buprenorphine transdermal and pentobarbital both equall